Onepot AI

10/10
Not specified in article$13M (latest round reported)Not specified in article

Description

A company building an AI-enabled small-molecule synthesis platform; the company is home to a small-molecule synthesis lab called POT-1.

Why in News

Announced a $13M funding round to support its AI-driven chemical synthesis work and the operation/scale of its POT-1 small-molecule synthesis lab.

Founders

Daniil Boiko; Andrei Tyrin

Published

January 20, 2026

Website

Not specified in article

Analysis

Company name and headline explicitly reference AI applied to drug/chemistry workflows — clearly an AI startup.